Inspire Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$411K Buy
447
+223
+100% +$226K 0.03% 405
2025
Q4
$241K Buy
+224
New +$214K 0.02% 450
2024
Q1
Sell
-407
Closed -$237K 402
2023
Q4
$237K Sell
407
-13
-3% -$7.59K 0.04% 265
2023
Q3
$226K Buy
+420
New +$216K 0.04% 241

Other funds holding LLY

Inspire Advisors's LLY Position: Q1 2026 in Review

Inspire Advisors increased its Eli Lilly (LLY) stake by 100% in Q1 2026, buying an estimated $226K and bringing the position to 447 shares worth $411K. The position accounts for 0.03% of the portfolio, ranked #405.

Inspire Advisors first reported a position in LLY in Q3 2023 and has held it in 4 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Inspire Advisors held 447 shares of Eli Lilly worth $411K as of Q1 2026.
  • Inspire Advisors bought 223 Eli Lilly shares in Q1 2026, an estimated $226K.
  • Eli Lilly made up 0.03% of Inspire Advisors's portfolio in Q1 2026, its #405 holding.
  • Inspire Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 4 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Inspire Advisors's 13F filing for Q1 2026, filed 15 May 2026.